175 related articles for article (PubMed ID: 18215438)
1. Elevated expression of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM-1) is associated with increased angiogenic potential in non-small-cell lung cancer.
Dango S; Sienel W; Schreiber M; Stremmel C; Kirschbaum A; Pantel K; Passlick B
Lung Cancer; 2008 Jun; 60(3):426-33. PubMed ID: 18215438
[TBL] [Abstract][Full Text] [Related]
2. Elevated expression of carcinoembryonic antigen-related cell adhesion molecule 1 promotes progression of non-small cell lung cancer.
Sienel W; Dango S; Woelfle U; Morresi-Hauf A; Wagener C; Brümmer J; Mutschler W; Passlick B; Pantel K
Clin Cancer Res; 2003 Jun; 9(6):2260-6. PubMed ID: 12796394
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of angiogenesis assessment with anti-factor-VIII and anti-CD31 immunostaining in non-small cell lung cancer.
Giatromanolaki A; Koukourakis MI; Theodossiou D; Barbatis K; O'Byrne K; Harris AL; Gatter KC
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2485-92. PubMed ID: 9815651
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of Ang-2 mRNA in non-small cell lung cancer: association with angiogenesis and poor prognosis.
Takanami I
Oncol Rep; 2004 Oct; 12(4):849-53. PubMed ID: 15375511
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer.
Koukourakis MI; Giatromanolaki A; Thorpe PE; Brekken RA; Sivridis E; Kakolyris S; Georgoulias V; Gatter KC; Harris AL
Cancer Res; 2000 Jun; 60(11):3088-95. PubMed ID: 10850461
[TBL] [Abstract][Full Text] [Related]
6. Tumour necrosis factor-alpha and transforming growth factor-beta are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL-2-mediated neovascularization.
Boldrini L; Calcinai A; Samaritani E; Pistolesi F; Mussi A; Lucchi M; Angeletti CA; Basolo F; Fontanini G
Br J Cancer; 2000 Aug; 83(4):480-6. PubMed ID: 10945495
[TBL] [Abstract][Full Text] [Related]
7. Blood vessel invasion by tumor cells predicts recurrence in completely resected T1 N0 M0 non-small-cell lung cancer.
Macchiarini P; Fontanini G; Hardin MJ; Chuanchieh H; Bigini D; Vignati S; Pingitore R; Angeletti CA
J Thorac Cardiovasc Surg; 1993 Jul; 106(1):80-9. PubMed ID: 8391612
[TBL] [Abstract][Full Text] [Related]
8. Microvessel count predicts metastatic disease and survival in non-small cell lung cancer.
Fontanini G; Bigini D; Vignati S; Basolo F; Mussi A; Lucchi M; Chine S; Angeletti CA; Harris AL; Bevilacqua G
J Pathol; 1995 Sep; 177(1):57-63. PubMed ID: 7472781
[TBL] [Abstract][Full Text] [Related]
9. Glomeruloid microvascular proliferation is superior to intratumoral microvessel density as a prognostic marker in non-small cell lung cancer.
Tanaka F; Oyanagi H; Takenaka K; Ishikawa S; Yanagihara K; Miyahara R; Kawano Y; Li M; Otake Y; Wada H
Cancer Res; 2003 Oct; 63(20):6791-4. PubMed ID: 14583475
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer.
Chen JJ; Yao PL; Yuan A; Hong TM; Shun CT; Kuo ML; Lee YC; Yang PC
Clin Cancer Res; 2003 Feb; 9(2):729-37. PubMed ID: 12576442
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of angiogenesis in operable non-small cell lung cancer.
Giatromanolaki A; Koukourakis M; O'Byrne K; Fox S; Whitehouse R; Talbot DC; Harris AL; Gatter KC
J Pathol; 1996 May; 179(1):80-8. PubMed ID: 8691350
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical study on tumor angiogenic factors in non-small cell lung cancer.
Aikawa H; Takahashi H; Fujimura S; Sato M; Endo C; Sakurada A; Kondo T; Tanita T; Matsumura Y; Ono S; Saito Y; Sagawa M
Anticancer Res; 1999; 19(5B):4305-9. PubMed ID: 10628391
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival.
Fontanini G; De Laurentiis M; Vignati S; Chinè S; Lucchi M; Silvestri V; Mussi A; De Placido S; Tortora G; Bianco AR; Gullick W; Angeletti CA; Bevilacqua G; Ciardiello F
Clin Cancer Res; 1998 Jan; 4(1):241-9. PubMed ID: 9516978
[TBL] [Abstract][Full Text] [Related]
14. Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer.
Harpole DH; Richards WG; Herndon JE; Sugarbaker DJ
Ann Thorac Surg; 1996 May; 61(5):1470-6. PubMed ID: 8633961
[TBL] [Abstract][Full Text] [Related]
15. [Expression of plakoglobin in bronchial carcinomas: incidence and significance for disease outcome].
Passlick B; Pantel K; Stosiek P; Hosch S; Thetter O; Izbicki JR
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():810-3. PubMed ID: 9101995
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma.
Herbst RS; Yano S; Kuniyasu H; Khuri FR; Bucana CD; Guo F; Liu D; Kemp B; Lee JJ; Hong WK; Fidler IJ
Clin Cancer Res; 2000 Mar; 6(3):790-7. PubMed ID: 10741698
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of gelsolin expression level and variability in non-small cell lung cancer.
Yang J; Tan D; Asch HL; Swede H; Bepler G; Geradts J; Moysich KB
Lung Cancer; 2004 Oct; 46(1):29-42. PubMed ID: 15364130
[TBL] [Abstract][Full Text] [Related]
18. Flt-4-positive endothelial cell density and its clinical significance in non-small cell lung cancer.
Chen F; Takenaka K; Ogawa E; Yanagihara K; Otake Y; Wada H; Tanaka F
Clin Cancer Res; 2004 Dec; 10(24):8548-53. PubMed ID: 15623638
[TBL] [Abstract][Full Text] [Related]
19. Cyclin E expression, a potential prognostic marker for non-small cell lung cancers.
Mishina T; Dosaka-Akita H; Hommura F; Nishi M; Kojima T; Ogura S; Shimizu M; Katoh H; Kawakami Y
Clin Cancer Res; 2000 Jan; 6(1):11-6. PubMed ID: 10656426
[TBL] [Abstract][Full Text] [Related]
20. Expression of CEACAM6 in resectable colorectal cancer: a factor of independent prognostic significance.
Jantscheff P; Terracciano L; Lowy A; Glatz-Krieger K; Grunert F; Micheel B; Brümmer J; Laffer U; Metzger U; Herrmann R; Rochlitz C
J Clin Oncol; 2003 Oct; 21(19):3638-46. PubMed ID: 14512395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
